All In MedTech

FDA Clearance Tracker · P010047-S065

PROGEL Pleural Air Leak Sealant

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 9, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 9, 2022

Approved

Time to decision

344 days

Received Mar 2, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010047-S065
Device name
PROGEL Pleural Air Leak Sealant
Applicant
Neomend, Inc.
Applicant location
Irvine, CA
Received
Mar 2, 2021
Decided
Feb 9, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P010047

Device type

Device class
Class III

Every decision under product code NBE

FDA's approval statement

As written in FDA's record.

Approval for labeling changes.

Source documents

Other decisions for Neomend, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.